Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.

Cardiac troponin I (cTnI) is the inhibitory component of the troponin complex and is involved in the calcium control of heart muscle contraction. Recently, specific missense mutations of the cTnI gene (TNNI3) have been shown to cause familial hypertrophic cardiomyopathy (HCM). We have analyzed the f...

Full description

Bibliographic Details
Main Authors:	Elliott, K, Watkins, H, Redwood, C
Format:	Journal article
Language:	English
Published:	2000

Similar Items

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
by: Elliott, K, et al.
Published: (2000)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
by: Robinson, P, et al.
Published: (2002)

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
by: Redwood, C, et al.
Published: (2000)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
by: Burton, D, et al.
Published: (2000)

A troponin I mutant known to cause hypertrophic cardiomyopathy shows reduced inhibition of Ca2+ independent tension
by: Burton, D, et al.
Published: (2000)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
by: Bing, W, et al.
Published: (2000)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
by: Redwood, C, et al.
Published: (2001)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
by: Robinson, P, et al.
Published: (2007)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
by: Robinson, P, et al.
Published: (2010)

Ca2+regulatory properties of a truncated troponin T that causes FHC depend on the ratio of mutant to wild-type peptide.
by: Redwood, C, et al.
Published: (2000)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
by: Mogensen, J, et al.
Published: (2004)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
by: Robinson, P, et al.
Published: (2007)

Cardiac troponin and tropomyosin: structural and cellular perspectives to unveil the Hypertrophic Cardiomyopathy phenotype
by: Mayra de A. Marques, et al.
Published: (2016-09-01)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
by: Toru Kubo, et al.
Published: (2020-12-01)

Abnormally high values of cardiac troponin i in hypertrophic cardiomyopathy and diastolic heart failure
by: Lazić S., et al.
Published: (2014-01-01)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
by: Bayliss, C, et al.
Published: (2013)

Human-based computational investigations into cardiac electromechanical alterations caused by drugs and hypertrophic cardiomyopathy
by: Margara, F
Published: (2021)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
by: Redwood, C, et al.
Published: (2004)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
by: Preston, L, et al.
Published: (2006)

Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I*.
by: Alison Y Li, et al.
Published: (2013-01-01)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
by: Messer, A, et al.
Published: (2016)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
by: Jose R. Pinto, et al.
Published: (2017-04-01)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
by: Carballo, S, et al.
Published: (2006)

Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy
by: Karissa M. Dieseldorff Jones, et al.
Published: (2020-03-01)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
by: Mirza, M, et al.
Published: (2004)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

An in silico analysis of troponin I mutations in hypertrophic cardiomyopathy of Indian origin.
by: Gayatri Ramachandran, et al.
Published: (2013-01-01)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
by: Robinson, P, et al.
Published: (2007)

Crossbridge Recruitment Capacity of Wild-Type and Hypertrophic Cardiomyopathy-Related Mutant Troponin-T Evaluated by X-ray Diffraction and Mechanical Study of Cardiac Skinned Fibers
by: Maki Yamaguchi, et al.
Published: (2020-05-01)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy
by: Stefanie Hasler, et al.
Published: (2016-03-01)

Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats
by: S. Hertzsch, et al.
Published: (2019-05-01)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
by: Marston, S, et al.
Published: (2009)